These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 25028262

  • 21. Preclinical studies of the proteasome inhibitor bortezomib in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Maulik G, Mukhopadhyay L, Yeap BY, Kindler HL, Salgia R, Sugarbaker DJ, Bueno R.
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):549-58. PubMed ID: 17522864
    [Abstract] [Full Text] [Related]

  • 22. Natural diterpenes from coffee, cafestol and kahweol induce apoptosis through regulation of specificity protein 1 expression in human malignant pleural mesothelioma.
    Lee KA, Chae JI, Shim JH.
    J Biomed Sci; 2012 Jun 26; 19(1):60. PubMed ID: 22734486
    [Abstract] [Full Text] [Related]

  • 23. Cisplatin-Chelated Iminodiacetic Acid-Conjugated Hyaluronic Acid Nanogels for the Treatment of Malignant Pleural Mesothelioma in Mice.
    Amano Y, Sakura KL, Ohta S, Ito T.
    Mol Pharm; 2022 Mar 07; 19(3):853-861. PubMed ID: 35142223
    [Abstract] [Full Text] [Related]

  • 24. In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes.
    Papazoglou ED, Jagirdar RM, Kouliou OA, Pitaraki E, Hatzoglou C, Gourgoulianis KI, Zarogiannis SG.
    Cancers (Basel); 2019 Sep 27; 11(10):. PubMed ID: 31569615
    [Abstract] [Full Text] [Related]

  • 25. Newly synthesized anticancer drug HUHS1015 is effective on malignant pleural mesothelioma.
    Kaku Y, Nagaya H, Tsuchiya A, Kanno T, Gotoh A, Tanaka A, Shimizu T, Nakao S, Tabata C, Nakano T, Nishizaki T.
    Cancer Sci; 2014 Jul 27; 105(7):883-9. PubMed ID: 24754309
    [Abstract] [Full Text] [Related]

  • 26. Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts.
    Lam SK, Li YY, Xu S, Leung LL, U KP, Zheng YF, Cheng PN, Ho JC.
    Respir Res; 2017 May 02; 18(1):80. PubMed ID: 28464918
    [Abstract] [Full Text] [Related]

  • 27. E7080, a multi-tyrosine kinase inhibitor, suppresses the progression of malignant pleural mesothelioma with different proangiogenic cytokine production profiles.
    Ikuta K, Yano S, Trung VT, Hanibuchi M, Goto H, Li Q, Wang W, Yamada T, Ogino H, Kakiuchi S, Uehara H, Sekido Y, Uenaka T, Nishioka Y, Sone S.
    Clin Cancer Res; 2009 Dec 01; 15(23):7229-37. PubMed ID: 19934291
    [Abstract] [Full Text] [Related]

  • 28. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma.
    Dell'Anno I, Martin SA, Barbarino M, Melani A, Silvestri R, Bottaro M, Paolicchi E, Corrado A, Cipollini M, Melaiu O, Giordano A, Luzzi L, Gemignani F, Landi S.
    Invest New Drugs; 2021 Jun 01; 39(3):644-657. PubMed ID: 33300108
    [Abstract] [Full Text] [Related]

  • 29. Inhibitor of apoptosis proteins are regulated by tumour necrosis factor-alpha in malignant pleural mesothelioma.
    Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, Bueno R.
    J Pathol; 2007 Mar 01; 211(4):439-46. PubMed ID: 17253597
    [Abstract] [Full Text] [Related]

  • 30. Inhibition of epidermal growth factor receptor signaling in malignant pleural mesothelioma.
    Jänne PA, Taffaro ML, Salgia R, Johnson BE.
    Cancer Res; 2002 Sep 15; 62(18):5242-7. PubMed ID: 12234991
    [Abstract] [Full Text] [Related]

  • 31. RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model.
    Mabuchi S, Altomare DA, Cheung M, Zhang L, Poulikakos PI, Hensley HH, Schilder RJ, Ozols RF, Testa JR.
    Clin Cancer Res; 2007 Jul 15; 13(14):4261-70. PubMed ID: 17634556
    [Abstract] [Full Text] [Related]

  • 32. Resveratrol contributes to chemosensitivity of malignant mesothelioma cells with activation of p53.
    Lee YJ, Park IS, Lee YJ, Shim JH, Cho MK, Nam HS, Park JW, Oh MH, Lee SH.
    Food Chem Toxicol; 2014 Jan 15; 63():153-60. PubMed ID: 24239893
    [Abstract] [Full Text] [Related]

  • 33. The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice.
    Li Q, Yano S, Ogino H, Wang W, Uehara H, Nishioka Y, Sone S.
    Clin Cancer Res; 2007 Oct 01; 13(19):5918-25. PubMed ID: 17908988
    [Abstract] [Full Text] [Related]

  • 34. In Vitro and In Vivo Antitumor Activity of [Pt(O,O'-acac)(γ-acac)(DMS)] in Malignant Pleural Mesothelioma.
    Muscella A, Vetrugno C, Cossa LG, Antonaci G, De Nuccio F, De Pascali SA, Fanizzi FP, Marsigliante S.
    PLoS One; 2016 Oct 01; 11(11):e0165154. PubMed ID: 27806086
    [Abstract] [Full Text] [Related]

  • 35. Curcumin suppresses growth of mesothelioma cells in vitro and in vivo, in part, by stimulating apoptosis.
    Wang Y, Rishi AK, Wu W, Polin L, Sharma S, Levi E, Albelda S, Pass HI, Wali A.
    Mol Cell Biochem; 2011 Nov 01; 357(1-2):83-94. PubMed ID: 21594647
    [Abstract] [Full Text] [Related]

  • 36. Putative cancer stem cells in malignant pleural mesothelioma show resistance to cisplatin and pemetrexed.
    Cortes-Dericks L, Carboni GL, Schmid RA, Karoubi G.
    Int J Oncol; 2010 Aug 01; 37(2):437-44. PubMed ID: 20596671
    [Abstract] [Full Text] [Related]

  • 37. Effect of citrate on malignant pleural mesothelioma cells: a synergistic effect with cisplatin.
    Zhang X, Varin E, Allouche S, Lu Y, Poulain L, Icard P.
    Anticancer Res; 2009 Apr 01; 29(4):1249-54. PubMed ID: 19414371
    [Abstract] [Full Text] [Related]

  • 38. Interaction and cross-resistance of cisplatin and pemetrexed in malignant pleural mesothelioma cell lines.
    Kitazono-Saitoh M, Takiguchi Y, Kitazono S, Ashinuma H, Kitamura A, Tada Y, Kurosu K, Sakaida E, Sekine I, Tanabe N, Tagawa M, Tatsumi K.
    Oncol Rep; 2012 Jul 01; 28(1):33-40. PubMed ID: 22562354
    [Abstract] [Full Text] [Related]

  • 39. Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma.
    Di Marzo D, Forte IM, Indovina P, Di Gennaro E, Rizzo V, Giorgi F, Mattioli E, Iannuzzi CA, Budillon A, Giordano A, Pentimalli F.
    Cell Cycle; 2014 Jul 01; 13(4):652-65. PubMed ID: 24345738
    [Abstract] [Full Text] [Related]

  • 40. Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin.
    Ravera M, Gabano E, Zanellato I, Bonarrigo I, Escribano E, Moreno V, Font-Bardia M, Calvet T, Osella D.
    Dalton Trans; 2012 Mar 21; 41(11):3313-20. PubMed ID: 22286213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.